Explore 3 Stock Ideas & Industry Insights Download Free Report

NewGenIvf Group Limited Class A Ordinary Shares

Company price
0.4565 USD -0.03 ( 6.30%)
Last update at 2026-11-06T21:06:00Z
VOLUME
78023
Market Cap
1.79M

Momentum Score

…

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.45
Low
0.49
High
52 Week Price Range
0.81
Low
1539.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.49
Dividend Yield
-
Revenue TTM
4.73M
Revenue Per Share
308.19
Gross Profit TTM
0.96M
Debt / Equity
0.18
ROE
79.40%
Net Debt
4.11M
ROCE
34.08%
Diluted EPS TTM
296.80

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 9.73M -0.96M -0.69M 0.34M 0.16M
Minority interest 0.15M -0.05M 0.02M 0.32M 0.14M
Net income 9.88M -0.53M -0.69M 0.46M -0.00M
Selling general administrative 10.49M 2.78M 1.62M 1.10M 0.80M
Selling and marketing expenses 1.19M 0.21M 0.02M 0.04M 0.02M
Gross profit 0.96M 1.83M 1.68M 1.54M 1.02M
Reconciled depreciation 0.50M 0.21M 0.23M 0.30M 0.34M
Ebit 10.35M -0.18M -2.75M 0.42M 0.24M
Ebitda 10.84M 0.02M -2.52M 0.73M 0.59M
Depreciation and amortization 0.50M 0.21M 0.23M 0.30M 0.34M
Operating income -10.73M -1.16M -2.52M 0.40M 0.20M
Other operating expenses 15.45M 6.59M 2.52M 5.55M 3.92M
Interest expense 0.62M 0.78M 0.05M 0.08M 0.09M
Tax provision 0.00M -0.49M 0.00M 0.21M 0.29M
Interest income 0.00M 0.01M 0.00M 0.00M 0.00M
Net interest income -0.61M -0.77M -0.05M -0.08M -0.09M
Income tax expense - -0.49M -0.23M 0.21M 0.29M
Total revenue 4.73M 5.43M 5.14M 5.94M 4.12M
Total operating expenses 11.68M 2.99M 2.52M 1.14M 0.83M
Cost of revenue 3.77M 3.61M 3.45M 4.41M 3.09M
Total other income expense net 20.46M 0.20M 1.83M -0.05M -0.04M
Net income from continuing ops 9.73M -0.47M 0.11M 0.14M -0.14M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 32.72M 3.58M 21.32M 2.90M 1.41M
Intangible assets 23.05M - - - -
Other current assets 5.22M 0.27M 0.01M -2.33M -
Total liab 6.74M 5.06M 5.72M 2.80M 2.33M
Total stockholder equity 26.63M -1.05M 15.60M 0.56M -0.78M
Other current liab 0.98M 0.65M 0.44M 0.32M 0.25M
Common stock - 21.27M 21.27M 0.01M 0.01M
Capital stock 0.00M 0.00M 0.01M 0.01M 0.01M
Retained earnings 8.89M -0.99M -5.67M -0.59M -1.05M
Other assets - -0.20M - - -
Cash 0.76M 0.46M 0.04M 0.03M 0.03M
Total current liabilities 2.37M 2.72M 2.24M 2.56M 2.07M
Current deferred revenue 0.11M 0.06M 0.01M 1.36M 0.81M
Net debt 4.11M 2.57M 1.58M 0.42M 0.90M
Short term debt 0.49M 0.69M 1.62M 0.20M 0.66M
Short long term debt 0.26M 0.58M - - 0.51M
Short long term debt total 4.86M 3.03M 1.62M 0.45M 0.93M
Other stockholder equity 17.88M -0.08M 0.01M 1.14M 0.26M
Total current assets 7.38M 3.17M 0.05M 2.40M 0.82M
Short term investments - 0.01M - - -
Net receivables 1.07M 2.36M 1.02M 2.32M 0.75M
Long term debt 4.10M 2.33M - - -
Inventory 0.34M 0.08M 0.13M 0.05M 0.04M
Accounts payable 0.78M 1.30M 0.17M 0.10M 0.05M
Accumulated other comprehensive income -0.14M 0.02M -0.01M 0.01M 0.01M
Non currrent assets other 1.63M 0.03M -0.45M -0.51M -
Non current assets total 25.34M 0.61M 21.27M 0.51M 0.59M
Capital lease obligations 0.51M 0.12M 0.33M 0.45M 0.41M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -0.76M -0.05M -0.07M -0.09M -0.02M
Total cashflows from investing activities -7.56M -0.05M - -69.69M -0.02M
Net borrowings 6.34M 8.58M -0.01M 0.11M 0.50M
Total cash from financing activities 18.99M 8.68M -50.41M 70.27M -1.54M
Net income 9.73M -0.47M -0.69M 0.50M -0.14M
Change in cash 0.30M 0.40M -0.01M 0.05M -0.08M
Begin period cash flow 0.46M 0.05M 0.05M 0.03M 0.11M
End period cash flow 0.76M 0.46M 0.04M 0.05M 0.03M
Total cash from operating activities -10.93M -8.26M -0.86M -0.53M 1.43M
Issuance of capital stock 12.62M 0.00M 0.19M 0.00M 0.00M
Depreciation 0.50M 0.21M 0.23M 0.30M 0.34M
Other cashflows from investing activities -1.00M 0.78M - 0.09M -
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory -0.25M 0.05M -0.08M -0.01M 0.00M
Change to account receivables -0.54M -0.04M 0.00M 0.13M 0.06M
Other cashflows from financing activities 0.03M 0.10M -52.03M -1.71M -2.04M
Capital expenditures 5.75M 0.05M 0.07M 0.09M 0.02M
Change in working capital -1.60M -7.76M 1.66M 0.71M 0.73M
Other non cash items -19.55M 0.25M -2.39M -2.25M 0.50M
Free cash flow -16.68M -8.32M -0.93M -0.62M 1.42M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NIVF
NewGenIvf Group Limited Class A Ordinary Shares
-0.03
6.30%
0.46 - 0.01 0.38 0.07 1.31 0.57
HCA
HCA Healthcare, Inc.
-12.49
2.46%
494.99 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-3.13
1.09%
283.33 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
0.06
0.42%
14.62 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-
-%
5.28 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

NewGenIvf Group Limited Class A Ordinary Shares

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

PS Tower,36/39-36/40, Bangkok, Thailand, 10110

66 2 116 9641

87

Name Title Year Born
Mr. Wing Fung Siu Co-Founder, Chairman & CEO 1956
Ms. Hei Yue Fong Co-Founder, Chief Marketing Officer & Director 1982
Mr. Ho Fai Chung Chief Financial Officer 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…